Ira Duarte insider trades
Open-market stock purchases and sales by Ira Duarte, EVP, Chief Financial Officer at Heron Therapeutics, Inc /de/, from SEC Form 4 filings since Mar 2, 2011.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -52%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 16, 2026 | HRTX Heron Therapeutics, Inc /de/ | Sold (not open market) | $1.4K |
| Jun 16, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Apr 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 31, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 30, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Jan 19, 2026 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Oct 31, 2025 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |
| Oct 19, 2025 | HRTX Heron Therapeutics, Inc /de/ | Bought (not open market) | — |